In the United States, difficulties in getting treatment for substance use disorders during the COVID pandemic coincided with a jump in use of synthetic opioids like fentanyl, and opioid-related deaths soared to a record-high in 2020.
https://www.pharmalive.com/wp-content/uploads/2021/04/U.S.-Justice-Department-backs-extending-ban-on-fentanyl-copycats-Reuters-4-13-21.jpeg246370Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-05-03 00:26:092023-05-03 09:58:32US fentanyl-related deaths more than tripled over five years
